Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
about
Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates.Investigation of mechanism of drug-induced cardiac injury and torsades de pointes in cynomolgus monkeys.Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.High throughput measurement of Ca²⁺ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometrySerum biomarkers reveal long-term cardiac injury in isoproterenol-treated African green monkeys.Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.Exploratory safety pharmacology: a new safety paradigm to de-risk drug candidates prior to selection for regulatory science investigations.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Phenotypic profiling of structural cardiotoxins in vitro reveals dependency on multiple mechanisms of toxicity.Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery.Mode of treatment governs curcumin response on doxorubicin-induced toxicity in cardiomyoblasts.Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
P2860
Q34669434-4848DD77-8E55-4202-A1B1-3D34A231C6ECQ36176544-A4F0FD56-76EF-4EB3-A712-A5D06018F900Q36683233-EE5DB206-73BB-4B2D-8A1A-1DE57B3D2901Q36886861-5202EC93-221E-4BB2-8879-2D24DE00870BQ37266056-BCFD3049-D944-4F5C-BE53-99831B5E7567Q37573646-9BEBFE1A-A63A-4209-B638-45717C29F00CQ37649640-F0700400-7948-4BF5-80C2-12E69C165662Q38874111-43722CB8-3994-4981-98A1-54DB66D372DAQ39211305-57E7FC9E-F439-4210-9580-B121CCC32923Q39379692-00662E2A-53B1-408A-9776-604B61B68B5BQ39812568-B3E82478-3E2A-4C6B-A6AC-BEF011BF75BEQ39856747-BC4B8A54-6A45-447F-BF36-0C68AA8E745CQ46304110-7AEB0F01-03F4-4966-9998-15805CAB7886Q47611653-C51674D9-5600-4A28-9BD3-69529FD61A67
P2860
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
@en
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
@nl
type
label
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
@en
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
@nl
prefLabel
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
@en
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
@nl
P2093
P2860
P1476
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
@en
P2093
Judith K Gwathmey
Katya Tsaioun
Roger J Hajjar
P2860
P304
P356
10.1517/17425250902932915
P407
P577
2009-06-01T00:00:00Z